to describe the management, filing, and verification of essential documents required before the initiation of a clinical trial, in accordance with ICH E6 §8, GCP, and global regulatory authority expectations. These documents collectively demonstrate trial preparation, regulatory compliance, and readiness for initiation.

Scope

This SOP applies to all clinical trials sponsored or managed by the organization and covers sponsor, CRO, investigator site, and vendor responsibilities for generating, collecting, and filing essential documents before trial initiation. It includes regulatory approvals, contracts, study-specific records, and readiness assessments.

Responsibilities

• Sponsor: Ensures all pre-trial essential documents are collected, filed, and verified.
• CRO: Collects and files documents on behalf of sponsor when delegated.
• Investigator: Provides site-level documents such as CVs, training records, and ISF setup.
• QA: Conducts pre-trial TMF review and audit readiness check.
• Regulatory Affairs: Provides regulatory submissions and approvals.
• Clinical Operations: Ensures all contracts, logs, and templates are filed.

Accountability

Sponsor is accountable for ensuring completeness and accuracy of essential documents before trial start. QA is accountable for verifying readiness, while CRO and investigators are responsible for document provision.

Procedure

1. Protocol and Related Documents
1.1 File final protocol, protocol amendments (if any), and synopsis in TMF/ISF.
1.2 File protocol signature page with sponsor, investigator, and approval authority signatures.
1.3 File Investigator Brochure (IB) and any updates.

2. Regulatory and Ethics Approvals
2.1 File EC/IRB approval letter for protocol, informed consent, and recruitment materials.
2.2 File regulatory authority approvals (e.g., IND, CTA, CTN approval letters).
2.3 File correspondence with authorities in Regulatory Correspondence Log (Annexure-1).

3. Informed Consent Templates
3.1 File approved informed consent form templates, including local language versions.
3.2 Ensure that assent forms for pediatric trials are included.
3.3 Maintain Consent Template Log (Annexure-2).

4. Site and Investigator Documentation
4.1 File CVs and medical licenses for PI and sub-investigators.
4.2 File GCP and protocol training certificates.
4.3 File Delegation of Authority Log (Annexure-3).

5. Contracts and Agreements
5.1 File CRO, vendor, and site contracts with scope of work, timelines, and compliance clauses.
5.2 File financial disclosure forms of investigators.
5.3 File insurance and indemnity certificates.

6. Facility and Laboratory Documentation
6.1 File site qualification checklist and initiation visit reports.
6.2 File laboratory certifications, accreditations, and normal ranges.
6.3 File equipment calibration and maintenance certificates.

7. Investigational Product Documentation
7.1 File regulatory approvals for labeling and import/export licenses.
7.2 File IP labeling and accountability plan.
7.3 File IP shipping and storage arrangements documentation.

8. Verification and Quality Control
8.1 TMF Administrator maintains Essential Documents Checklist (Annexure-4).
8.2 QA verifies all documents are filed before initiation meeting.
8.3 Missing documents must be tracked in Pre-Trial Document Gap Log (Annexure-5).

Abbreviations

• SOP: Standard Operating Procedure
• TMF/ISF: Trial Master File / Investigator Site File
• PI: Principal Investigator
• EC/IRB: Ethics Committee / Institutional Review Board
• IB: Investigator Brochure
• CRO: Contract Research Organization
• IP: Investigational Product
• QA: Quality Assurance

Documents

1. Regulatory Correspondence Log (Annexure-1)
2. Consent Template Log (Annexure-2)
3. Delegation of Authority Log (Annexure-3)
4. Essential Documents Checklist (Annexure-4)
5. Pre-Trial Document Gap Log (Annexure-5)

References

• ICH E6(R2/R3) – Section 8 Essential Documents
• FDA – Essential Documents Before Trial
• EMA – GCP Inspection Guidance
• CDSCO – Essential Documents Checklist
• WHO – Pre-Trial Documentation Requirements

Version: 1.0

Approval Section

Prepared By	Ravi Kumar, TMF Administrator
Checked By	Sunita Reddy, QA Officer
Approved By	Dr. Anil Sharma, Head Clinical Quality

Annexures

Annexure-1: Regulatory Correspondence Log

Date	Authority	Subject	Outcome	Filed By
10/09/2025	CDSCO	CTA Approval	Approved	Regulatory Affairs

Annexure-2: Consent Template Log

Version	Language	Approval Date	Approved By
v1.0	English	05/09/2025	EC
v1.0	Hindi	06/09/2025	EC

Annexure-3: Delegation of Authority Log

Name	Role	Task Delegated	Date Assigned	Signature
Dr. Neha Verma	PI	Overall Study Oversight	01/09/2025	Signed
Arjun Patel	Coordinator	Consent Process	01/09/2025	Signed

Annexure-4: Essential Documents Checklist

Document	Status	Remarks
Final Protocol	Filed	Approved version
Investigator Brochure	Filed	v5.0
EC Approval	Filed	Initial approval

Annexure-5: Pre-Trial Document Gap Log

Date	Document	Gap Identified	Action Taken	Status
12/09/2025	Lab Certification	Pending renewal	Requested from lab	Open

Revision History

Revision Date	Revision No.	Revision Details	Reason for Revision	Approved By
26/08/2025	00	Initial version	New SOP creation	Head Clinical Quality

For more SOPs visit: Pharma SOP